PharmaShots | Incisive News in 3 Shots

Subscribe Now

Telix

Telix to Acquire Therapeutic Assets & Biologics Platform from ImaginAb for ~$230M

Telix to Acquire Therapeutic Assets & Biologics Platform from ImaginAb for ~$230M

January 13, 2025

Telix to Expand its US Operations Through the Acquisition of RLS Radiopharmacies

Telix to Expand its US Operations Through the Acquisition of RLS Radiopharmacies

September 23, 2024

Telix Reports the Acquisition of ARTMS and its Advanced Isotope Production Platform

Telix Reports the Acquisition of ARTMS and its Advanced Isotope Production Platform

March 5, 2024

Telix to Acquire QSAM Biosciences to Enhance its Oncology Segment

Telix to Acquire QSAM Biosciences to Enhance its Oncology Segment

February 8, 2024

Telix Reports the First Patient Dosing of TLX101 in P-I Study (IPAX-2) for Newly Diagnosed Glioblastoma

Telix Reports the First Patient Dosing of TLX101 in P-I Study (IPAX-2) for Newly Diagnosed Glioblastoma

August 8, 2023

Telix Presented P-III Results from TLX250-CDx for Kidney Cancer Imaging Study at the ASCO GU 2023

Telix Presented P-III Results from TLX250-CDx for Kidney Cancer Imaging Study at the ASCO GU 2023

February 20, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us